Main Article Content


Recent drug delivery systems (DDS) are formulated using advanced technology to accelerate systemic drug delivery to the specific target site, maximizing therapeutic efficacy and minimizing off-target accumulation in the body [2].

 As a result, they play an important role in disease management and treatment. This is especially true for most life-threatening diseases requiring therapeutic agents with numerous side effects, thus requiring accurate tissue targeting to minimize systemic exposure.

Delivery strategies have greatly helped convert promising therapeutics into successful therapies. As the therapeutic landscape evolved, delivery strategies and technologies quickly adapted to changing drug delivery needs. A few decades ago, small-molecule drugs were the primary class of therapeutic [13].

Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation, facilitating patient compliance, and enabling entirely new medical treatments [17].

The components of the drug account for its physicochemical properties and are responsible for the changes it influences in the body. It, improves the drug solubility, target site accumulation, efficacy, pharmacological activity, pharmacokinetic properties, patient acceptance, and compliance, and reduces drug toxicity [2].

Innovation in delivery technologies and strategies has been catalyzed by the identification of unique delivery challenges associated with each class of therapeutics. As the therapeutic landscape evolved, delivery strategies and technologies quickly adapted to reflect changing drug delivery needs.


Drug Delivery systems Drug Delivery technologies Nanocarriers RBC Membrane ingestible injectables NGS Artificial intelligence 3D printing

Article Details

How to Cite
Challa Sahithi, & P Prathyusha Ande. (2023). A Review of Next-Generation Drug Delivery Systems And Technologies. International Journal of Research in Pharmacology & Pharmacotherapeutics, 12(4), 289-300. Retrieved from


  1. 1. Mohammed AA, Ahmad J, Kotta S, et al. 3D printing in medicine. Sci Direct J. 2021;4(2):84-97.
  2. 2. Vargason AM, Anselmo AC, Mitragotri S. The evaluation of commercial drug delivery technologies. Nature J. 2021;5(1):951-67.
  3. 3. Abramson A, Collins J, Landh T, et al. An ingestible self-orienting system for oral delivery of macromolecules. PMC (PubMed central) J. 2019;363(6427):611-5.
  4. 4. Nwike CP, Onoja UL, et al. Advances in drug delivery systems, challenges, and future directions.ScienceDirect J. 2023;9(20):2405-8440.
  5. 5. Jackson KK, Mata C, Marcus RK. A rapid capillary-channeled polymer (C-CP) fiber spin-down tip was approached for the isolation of plant-derived extracellular vesicles from 20 common fruit and vegetable sources. Nanobiotechnology J. 2022;252 (123779):213-28.
  6. 6. Khaled SA, Burley JC, Alexander MR, Roberts CJ. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm. 2014;461(1-2):105-11. doi: 10.1016/j.ijpharm.2013.11.021, PMID 24280018.
  7. 7. Vora LK, Chavda VP, Jetha K et al.… Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. MDPI J. 2023;15(7):119-27.
  8. 8. ullah M, wahab A, khalil ur Rehman, et al. 3D printing technology: A new approach for the fabrication of personalized and customized pharmaceuticals. Sciencedirect J. 2023;195(1122):25-76.
  9. 9. Mancilla-De-la-Cruz R-S, Chua CK, Tuck, et al. Three-dimensional printing technologies for drug delivery applications: processes, materials, and effects. Int J Bioprinting. 2022;8(622):146-56.
  10. 10. Martinez PR, Goyanes A, Basit AW, Gaisford S. Influence of geometry on the drug release profiles of stereolithographic (SLA) 3D-printed tablets. AAPS PharmSciTech. 2018;19(8):3355-61. doi: 10.1208/s12249-018-1075-3, PMID 29948979.
  11. 11. Shukla N, Bhargava H, Prasad A, et al. Next-generation sequencing. Res Gate J. 2021;5(8):277-302.
  12. 12. Xia Q, Li Z, Hou X, et al. RBCM- camouflaged nanoparticles. Sci Direct J. 2019;9(4):675-89.
  13. 13. Langer R, Karp JM, Joshi N et al.… The future of drug delivery. PMID PubMed J ,2023 ; 35 (2):359-63.
  14. 14. Ponni RTamil, Swamivelmanickam M, Krishnan SS. 3D printing technology. Int J Pharm Investig. 2020;10(1):8-12.
  15. 15. Garcia-Fandico R, Pinerio A, et al. The Role of AI in drug discovery: challenges, opportunities, and strategies. Int J Mol Sci. 2022;41:1427-73.
  16. 16. Sahoo S, Bagjadab AB, Priyadarshini SB, et al. Smart pills: A completely revolutionary technology than endoscopy. Pharm Chem Chem Sci J. 2020;5(6):275-303.
  17. 17. Stansbury JW, Idacavage MJ. 3D printing with polymers: challenges among expanding options and opportunities. Dent Mater. 2016;32(1):54-64. doi: 10.1016/, PMID 26494268.
  18. 18. Ezike TC, Okpala US, Onoja UL et al.… Advances in drug delivery systems, challenges, and future directions. ScienceDirect J. 2023;9(1):1-17.
  19. 19. Wang, Mullertz, Rantanen et al. structured approach for designing drug-loaded solid products by binder jetting 3D printing. Eur J Pharm Sci. 2022;178:(106280): 77-87.
  20. 20. Wang J, Goyanes A, Gaisford S, Basit AW. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm. 2016;503(1-2):207-12. doi: 10.1016/j.ijpharm.2016.03.016, PMID 26976500.
  21. 21. Zhang X, Chen Guopu, Fu X, et al. Mangeto- Responsive Microneedle Robots for intestinal macromolecule delivery. Wiley J. 2021;77(44):254-69.
  22. 22. Guan Y, Du S, et al. Extracellularvesicles: a rising star for therapeutics and drug delivery. Nanobiotechnology J .202;80:8-17.
  23. 23. Zhang Zhuohao, Shang Luoran, et al. Smart ingestible devices: orally delivering macromolecules and beyond. CelPress J. 2021;4(4):3372-84.
  24. 24. Mithani Z, Tabi K, Jang K, et al. Mobile Apps for medication management. 2019;7(9):1360-80. PMID PubMed (PMC) J.
  25. 25. zhang Zhuohao, et al. Data Analytics trends in the pharmaceutical industry. Infosys BPM J. 2023;5(6):75-89.